Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact on ductal carcinoma in situ progression.

Knudsen ES, Pajak TF, Qeenan M, McClendon AK, Armon BD, Schwartz GF, Witkiewicz AK.

J Natl Cancer Inst. 2012 Dec 5;104(23):1825-36. doi: 10.1093/jnci/djs446. Epub 2012 Nov 28.

PMID:
23197489
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.

Solin LJ, Gray R, Baehner FL, Butler SM, Hughes LL, Yoshizawa C, Cherbavaz DB, Shak S, Page DL, Sledge GW Jr, Davidson NE, Ingle JN, Perez EA, Wood WC, Sparano JA, Badve S.

J Natl Cancer Inst. 2013 May 15;105(10):701-10. doi: 10.1093/jnci/djt067. Epub 2013 May 2.

PMID:
23641039
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.

Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, Sanchez H, Jimenez C, Stewart K, Chew K, Ljung BM, Tlsty TD.

J Natl Cancer Inst. 2010 May 5;102(9):627-37. doi: 10.1093/jnci/djq101. Epub 2010 Apr 28. Erratum in: J Natl Cancer Inst. 2010 Jul 7;102(13):993.

PMID:
20427430
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer.

Witkiewicz AK, Cox DW, Rivadeneira D, Ertel AE, Fortina P, Schwartz GF, Knudsen ES.

Oncogene. 2014 Jul 24;33(30):3980-91. doi: 10.1038/onc.2013.367. Epub 2013 Oct 14.

PMID:
24121271
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.

Rakovitch E, Nofech-Mozes S, Hanna W, Narod S, Thiruchelvam D, Saskin R, Spayne J, Taylor C, Paszat L.

Br J Cancer. 2012 Mar 13;106(6):1160-5. doi: 10.1038/bjc.2012.41. Epub 2012 Feb 23.

PMID:
22361634
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study.

Zhou W, Jirström K, Johansson C, Amini RM, Blomqvist C, Agbaje O, Wärnberg F.

BMC Cancer. 2010 Nov 30;10:653. doi: 10.1186/1471-2407-10-653.

PMID:
21118480
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.

Ottesen GL.

APMIS Suppl. 2003;(108):1-67. Review.

PMID:
12874968
[PubMed - indexed for MEDLINE]
8.

Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer.

Chung MJ, Jung SH, Lee BJ, Kang MJ, Lee DG.

Pathol Int. 2004 Jan;54(1):10-5.

PMID:
14674989
[PubMed - indexed for MEDLINE]
9.

Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.

Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernster VL, Stewart K, Chew K, Moore DH 2nd, Waldman F.

J Natl Cancer Inst. 2003 Nov 19;95(22):1692-702.

PMID:
14625260
[PubMed - indexed for MEDLINE]
Free Article
10.

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.

Muggerud AA, Rønneberg JA, Wärnberg F, Botling J, Busato F, Jovanovic J, Solvang H, Bukholm I, Børresen-Dale AL, Kristensen VN, Sørlie T, Tost J.

Breast Cancer Res. 2010;12(1):R3. doi: 10.1186/bcr2466. Epub 2010 Jan 7.

PMID:
20056007
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment.

Witkiewicz AK, Rivadeneira DB, Ertel A, Kline J, Hyslop T, Schwartz GF, Fortina P, Knudsen ES.

Am J Pathol. 2011 Sep;179(3):1171-8. doi: 10.1016/j.ajpath.2011.05.043. Epub 2011 Jul 12.

PMID:
21756866
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer.

Mangé A, Lacombe J, Bascoul-Mollevi C, Jarlier M, Lamy PJ, Rouanet P, Maudelonde T, Solassol J.

Clin Cancer Res. 2012 Apr 1;18(7):1992-2000. doi: 10.1158/1078-0432.CCR-11-2527. Epub 2012 Feb 9.

PMID:
22322670
[PubMed - indexed for MEDLINE]
Free Article
13.

Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.

Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E.

J Natl Cancer Inst. 2008 Feb 20;100(4):243-51. doi: 10.1093/jnci/djn010. Epub 2008 Feb 12.

PMID:
18270338
[PubMed - indexed for MEDLINE]
Free Article
14.

EZH2 and ALDH1 expression in ductal carcinoma in situ: complex association with recurrence and progression to invasive breast cancer.

Knudsen ES, Dervishaj O, Kleer CG, Pajak T, Schwartz GF, Witkiewicz AK.

Cell Cycle. 2013 Jul 1;12(13):2042-50. doi: 10.4161/cc.25065. Epub 2013 Jun 6.

PMID:
23759596
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The Akt pathway in human breast cancer: a tissue-array-based analysis.

Bose S, Chandran S, Mirocha JM, Bose N.

Mod Pathol. 2006 Feb;19(2):238-45.

PMID:
16341149
[PubMed - indexed for MEDLINE]
Free Article
16.

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, Land SR, Margolese RG, Swain SM, Costantino JP, Wolmark N.

J Natl Cancer Inst. 2011 Mar 16;103(6):478-88. doi: 10.1093/jnci/djr027. Epub 2011 Mar 11.

PMID:
21398619
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS.

Nekhlyudov L, Habel LA, Achacoso N, Jung I, Haque R, Collins LC, Schnitt SJ, Quesenberry CP Jr, Fletcher SW.

J Natl Cancer Inst. 2012 Apr 18;104(8):614-21. doi: 10.1093/jnci/djs167. Epub 2012 Apr 5.

PMID:
22491230
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.

Wang L, Hoque A, Luo RZ, Yuan J, Lu Z, Nishimoto A, Liu J, Sahin AA, Lippman SM, Bast RC Jr, Yu Y.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3660-6.

PMID:
14506155
[PubMed - indexed for MEDLINE]
Free Article
19.

High expression of obesity-linked phosphatase SHIP2 in invasive breast cancer correlates with reduced disease-free survival.

Prasad NK, Tandon M, Handa A, Moore GE, Babbs CF, Snyder PW, Bose S.

Tumour Biol. 2008;29(5):330-41. doi: 10.1159/000172970. Epub 2008 Nov 15.

PMID:
19065064
[PubMed - indexed for MEDLINE]
20.

Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast.

Barnes NL, Khavari S, Boland GP, Cramer A, Knox WF, Bundred NJ.

Clin Cancer Res. 2005 Mar 15;11(6):2163-8.

PMID:
15788662
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk